Skip to search formSkip to main contentSkip to account menu

RMP-7

Known as: L-Prolinamide,L-Arginyl-L-protyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-02-004-0(aminoiminomethyl)amino)-1-0(4-methoxyphenyl)methyl)ethyl)-,0S-(R*,R*)), L-Prolinamide, L-arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-02-004-0((((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-0(((4-methoxyphenyl)methyl)ethyl)-, 0S-(R*,R*)-, RMP 7 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ABSTRACT Currently, the most effective tuberculosis control method involves case finding and 6 months of chemotherapy. There is a… 
2004
2004
RMP-7 is a bradykinin B2 receptor agonist shown to permeabilize the blood-brain barrier, especially that associated with brain… 
2001
2001
The successful conclusion of the first leprosy eradication program carried out with combination therapy is reported. This program… 
1997
1997
SummaryThe chemotherapy of tumours located in the brain is far from satisfactory, with very poor response rates even with tumour… 
1995
1995
Introduction ‐ Posatirelin (L‐pyro‐2–aminoadipyl‐L‐leucil‐L‐prolinamide) a new synthetic tripeptide with cholinergic… 
1995
1995
Several analogs of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N-[3,3,4,4,4-penta fluoro-1- (1-methylethyl)-2-oxobutyl]-L… 
1995
1995
PURPOSE To determine if the bradykinin agonist, RMP-7, could increase the ocular tissue concentration of agents that normally…